Many people are expressing frustration regarding the shortcomings of the company's press releases, including today's. We have repeatedly seen the company's reputation and stock price damaged by these communications.

I don't advocate bombarding any company with angry or nasty emails -- it's simply not productive. And CytoDyn is under immense pressure at this time, and they don't need unnecessary distractions.

However, I do think that, as shareholders, we have the right to calmly express constructive criticism regarding the confusion and damage that these press releases cause.

I have already sent my constructive email. I would suggest others who feel the same way, send their own emails.

Even though they are publicly available, I will not post the email addresses of the company executives in this message.